Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Kalyan Roy: LTOWB as a Practical Approach to Rapid Transfusion in Major Bleeding
Kalyan Roy/LinkedIn
Mar 21, 2026, 16:56

Kalyan Roy: LTOWB as a Practical Approach to Rapid Transfusion in Major Bleeding

Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:

“When seconds decide survival, one unit can change everything : Low-Titer Group O Whole Blood (LTOWB)

LTOWB is gaining momentum as a practical approach to rapid transfusion in major bleeding. By delivering red cells, plasma, and platelets in a single unit, it helps clinicians act faster and streamline resuscitation during critical moments.

What it means:
Group O blood means Red blood cells have no A or B antigens, so they can be given to almost anyone (universal donor for RBCs).

Whole blood means it contains all components:

  • Red blood cells (oxygen transport)
  • Plasma (with clotting factors)
  • Platelets (help stop bleeding)

Low titre means the donor’s plasma has low levels of anti-A and anti-B antibodies.

Why ‘low titre’ is important:
Normally, group O blood plasma contains anti-A and anti-B antibodies, which can attack a recipient’s red cells if they are not group O.

In LTOWB:
These antibodies are present in very low amounts
This reduces the risk of hemolytic reactions when transfused into non-O patients

Why it’s used:

LTOWB is commonly used in:

  • Severe trauma (e.g., accidents, war injuries)
  • Massive bleeding (hemorrhage)
  • Emergency settings where blood typing isn’t immediately available

Advantages:

  • Faster and simpler than giving separate components
  • Provides balanced resuscitation (RBCs with plasma and platelets together)
  • May improve survival in critical bleeding

Why it stands out:

  • Faster response with fewer components to manage
  • Supports early balanced resuscitation
  • Increasing adoption in both hospital and prehospital settings

What matters for safe implementation:

  • Clearly validated ‘low-titer’ testing and thresholds
  • Strict adherence to production and storage standards
  • A defined Rh strategy (who receives O-negative vs O-positive)

Getting started:

  • Select appropriate donors and set eligibility criteria
  • Establish clear clinical triggers for use
  • Track outcomes through hemovigilance and regular audits

Simple summary:
LTOWB is Whole blood from group O donors with low antibody levels, safe for emergency transfusion across different blood types.”

Kalyan Roy

Stay updated with Hemostasis Today.

bleeding Blood Health Hematology Hemophilia hemorrhage Hemostasis Hemostasis News Hemostasis Today Kalyan Roy LTOWB Medicine 𝗣𝗹𝗮𝘀𝗺𝗮 platelets Red Blood Cells (RBC) Transfusion Medicine
NewsFeed